LifeSci Acquisition II (LSAQ) Stock Price, News & Analysis

Company Overview

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

Key Stats

• Today's Range: N/A
• 50-Day Range: $9.01 to $14.10
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 53,514 shs
• Market Capitalization: $57.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LSAQ Stock Analysis - Frequently Asked Questions

When did LifeSci Acquisition II IPO?

LifeSci Acquisition II (LSAQ) raised $75 million in an initial public offering on Friday, November 20th 2020. The company issued 7,500,000 shares at a price of $10.00 per share. LifeSci Capital and Ladenburg Thalmann served as the underwriters for the IPO.

What other stocks do shareholders of LifeSci Acquisition II own?

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeSci Acquisition II investors own include Churchill Capital Corp IV (CCIV), Gores Holdings IV (GHIV), Qell Acquisition (QELLU), Altimeter Growth (AGCUU), AGBA Acquisition (AGBA), Edoc Acquisition (ADOCU) and ArcLight Clean Transition (ACTCU).

Company Calendar

• Today: 7/06/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Commercial Physical Research
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LSAQ
• CIK: 1819113
• Web: lifesciacquisition.com
• Phone: 646-899-1200
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.07
• Quick Ratio: 4.07

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.50 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,011,000
• Free Float: N/A
• Market Cap: $57.56 million
• Optionable: Not Optionable
• Beta: N/A